Opsens has already filed a patent application related to the product’s concept, being developed under ISO 13485 quality management system to obtain regulatory approval.

Opsens is always on the look out for new products and new markets to diversify its sources of revenues and to create value for its shareholders, said Claude Belleville, vice-president research and development. We believe that this innovative product will be an important breakthrough in medical devices.

Opsens wants to thank the NRC-IRAP for its advice in the planning of this project and for its financial contribution.